One year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal article

    K Reich, Dermatologikum Hamburg & Georg-August-University, Göttingen, Germany., L Puig, C Paul, K Kragballe, DenmarkT Luger, J Lambert, S Chimenti, G Girolomoni, J-F Nicolas, E Rizova, M Brunori, S Mistry, P Bergmans, J Barker
Original languageEnglish
JournalBritish Journal of Dermatology
StatePublished - 30 Sep 2013

See relations at Aarhus University Citationformats

ID: 69017971